Building and Sustaining Exercise Habits for Adults With Type 1 Diabetes
Launched by YALE UNIVERSITY · May 3, 2025
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring a new mobile app designed to help adults with type 1 diabetes, as well as other forms of diabetes that involve insulin deficiency, exercise more regularly and confidently. The app will provide personalized support, using information from continuous blood sugar monitoring, exercise habits, mood, and sleep patterns to encourage healthier behaviors. The goal is to make it easier for people with diabetes to stay active, which can be challenging due to their condition.
To be eligible for this study, participants must be between 30 and 65 years old and diagnosed with type 1 diabetes or another form of insulin deficiency. They should also currently exercise less than once a week and own a smartphone with internet access. Participants will need to provide recent data from a continuous glucose monitor and an insulin delivery method, like a pump or pen. Throughout the study, participants can expect to use the app over a certain period, receiving ongoing support and insights tailored to their individual health needs. This trial is not yet recruiting, but it aims to improve the lives of those managing diabetes by making exercise more accessible.
Gender
ALL
Eligibility criteria
- Inclusion criteria:
- • 30-65 years old inclusive
- • Diagnosis with type 1 diabetes (T1D) or other insulin deficiency diabetes (latent autoimmune disease of adulthood, diabetes secondary to pancreatitis)
- • Less than 1.0 exercise sessions per week
- • Smartphone ownership
- • English literacy
- • Under regular care by a healthcare provider (1+ appointments per year)
- • Home Broadband wireless Internet or cell phone network
- • Using continuous glucose monitor (CGM) and sharing data with medical record for at least 6 weeks
- • Using insulin pump or pen and sharing data with medical record for at least 6 weeks
- Exclusion criteria:
- • Diabetic ketoacidosis not clearly related to pump site failure in past 6 months
- • \>1 episode of severe hypoglycemia (altered mental and/or physical status requiring assistance from another person for recovery) in past 6 months
- • A1c ≥10.0%
- • Resting blood pressure \>160mmHg systolic or \>100 mmHg diastolic.
- • Myocardial infarction or angina in past 12 months
- • Uncontrolled arrhythmia (e.g., atrial fibrillation with rapid ventricular response, new onset atrial fibrillation, ventricular tachycardia, escape rhythms)
- • Congestive heart failure (stage 3 or 4)
- • Exercise-induced asthma (not controlled on inhalers)
- • Chronic obstructive pulmonary disease (requiring home oxygen)
- • Renal failure
- • Pregnancy
- • Cognitive impairment
- • Severe retinopathy or neuropathy.
- • Other chronic disease or physical disability that would influence exercise intervention (e.g., recent spinal surgery)
About Yale University
Yale University, a prestigious Ivy League institution located in New Haven, Connecticut, is renowned for its commitment to advancing medical research and clinical innovation. With a rich history of academic excellence and a robust infrastructure for scientific inquiry, Yale serves as a leading sponsor for clinical trials aimed at improving patient care and developing new therapeutic approaches. The university's multidisciplinary teams of researchers and clinicians collaborate to conduct rigorous and ethical studies, leveraging cutting-edge technologies and methodologies to address critical health challenges. Through its dedication to fostering an environment of inquiry and discovery, Yale University plays a pivotal role in translating research findings into clinical practice, ultimately enhancing health outcomes for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New Haven, Connecticut, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported